Robert Azelby - Feb 20, 2025 Form 3 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Director
Signature
/s/ David Strauss, as Attorney-in-Fact for Robert Azelby
Stock symbol
TERN
Transactions as of
Feb 20, 2025
Transactions value $
$0
Form type
3
Date filed
2/24/2025, 06:01 PM
Previous filing
Nov 7, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney